NCT00551018 Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875) Status COMPLETED Phase PHASE2
NCT00550771 Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) Status COMPLETED Phase PHASE2
NCT00550745 ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020) Status COMPLETED Phase PHASE4
NCT00550732 A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) Status COMPLETED Phase PHASE2
NCT00548080 Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) Status COMPLETED Phase PHASE3
NCT00546819 ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED) Status COMPLETED Phase PHASE2
NCT00546624 GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026) Status COMPLETED Phase PHASE2
NCT00546286 A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) Status COMPLETED Phase PHASE3
NCT00545584 Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078) Status COMPLETED Phase PHASE3
NCT00545064 Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) Status COMPLETED Phase PHASE4
NCT00543959 Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005) Status TERMINATED Phase PHASE2
NCT00543920 A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020) Status COMPLETED Phase PHASE2
NCT00543868 MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) Status COMPLETED Phase PHASE2
NCT00543816 MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030) Status TERMINATED Phase PHASE3
NCT00543751 Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025) Status TERMINATED Phase PHASE3
NCT00543595 MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005) Status COMPLETED Phase PHASE2